Estrogen After Hysterectomy May Do More Harm Than Good

SEPTEMBER 01, 2005

Postmenopausal women who have had a hysterectomy should not take estrogen replacement therapy (ERT) to prevent osteoporosis, stroke, or heart disease, according to new guidelines from the US Preventive Services Task Force. The recommendation was based on evidence from the ongoing Women's Health Initiative clinical trial, along with other studies. Although estrogen has positive effects, regular use of ERT may increase the risk of potentially fatal blood clots, stroke, dementia, and mild cognitive impairment. The task force stated that any benefits of ERT are outweighed by these harmful effects. The group encourages women to discuss other options for preventing bone fractures, cancer, or heart disease with their doctors.



SHARE THIS SHARE THIS
0

Become a Respimat Top Performer 

Get to know RESPIMAT, the slow-moving mist inhaler from Boehringer Ingelheim Pharmaceuticals, Inc. 

Watch the RESPIMAT video and test your knowledge with a short multiple-choice quiz. When you get all the answers right, you’ll receive a certificate naming you a RESPIMAT T.O.P. Performer. Why not check it out today? 

 

Pharmacy Times Strategic Alliance
 

Pharmacist Education
Clinical features with downloadable PDFs


Next-Generation Pharmacist® Awards


3rd Annual Convenient Healthcare and Pharmacy Collaborative Conference


SIGN UP FOR THE PHARMACY TIMES NEWSLETTER
Personalize the information you receive by selecting targeted content and special offers.